Authors:
Schuringa, JJ
Timmer, H
Luttickhuizen, D
Vellenga, E
Kruijer, W
Citation: Jj. Schuringa et al., c-Jun and c-Fos cooperate with STAT3 in IL-6-induced transactivation of the IL-6 response element (IRE), CYTOKINE, 14(2), 2001, pp. 78-87
Authors:
Schuringa, JJ
Dekker, LV
Vellenga, E
Kruijer, W
Citation: Jj. Schuringa et al., Sequential activation of Rac-1, SEK-1/MKK-4, and protein kinase C delta isrequired for interleukin-6-induced STAT3 Ser-727 phosphorylation and transactivation, J BIOL CHEM, 276(29), 2001, pp. 27709-27715
Authors:
Eggen, BJL
Benus, GFJD
Folkertsma, S
Jonk, LJ
Kruijer, W
Citation: Bjl. Eggen et al., TAK1 activation of the mouse JunB promoter is mediated through a CCAAT boxand NF-Y, FEBS LETTER, 506(3), 2001, pp. 267-271
Authors:
Schuringa, JJ
Schepers, H
Vellenga, E
Kruijer, W
Citation: Jj. Schuringa et al., Ser727-dependent transcriptional activation by association of p300 with STAT3 upon IL-6 stimulation, FEBS LETTER, 495(1-2), 2001, pp. 71-76
Authors:
Birkenkamp, KU
Esselink, MT
Kruijer, W
Vellenga, E
Citation: Ku. Birkenkamp et al., An inhibitor of PI3-K differentially affects proliferation and IL-6 protein secretion in normal and leukemic myeloid cells depending on the stage of differentiation, EXP HEMATOL, 28(11), 2000, pp. 1239-1249
Authors:
Schuringa, JJ
Jonk, LJC
Dokter, WHA
Vellenga, E
Kruijer, W
Citation: Jj. Schuringa et al., Interleukin-6-induced STAT3 transactivation and Ser(727) phosphorylation involves Vav, Rac-1 and the kinase SEK-1/MKK-4 as signal transduction components, BIOCHEM J, 347, 2000, pp. 89-96
Authors:
Birkenkamp, KU
Tuyt, LML
Lummen, C
Wierenga, LTJ
Kruijer, W
Vellenga, E
Citation: Ku. Birkenkamp et al., The p38 MAP kinase inhibitor SB203580 enhances nuclear factor-kappa B transcriptional activity by a non-specific effect upon the ERK pathway, BR J PHARM, 131(1), 2000, pp. 99-107
Authors:
Schuringa, JJ
Wierenga, ATJ
Kruijer, W
Vellenga, E
Citation: Jj. Schuringa et al., Constitutive Stat3, Tyr705, and Ser727 phosphorylation in acute myeloid leukemia cells caused by the autocrine secretion of interleukin-6, BLOOD, 95(12), 2000, pp. 3765-3770
Authors:
Pinaire, J
Hasanadka, R
Fang, M
Chou, WY
Stewart, MJ
Kruijer, W
Crabb, D
Citation: J. Pinaire et al., The retinoid X receptor response element in the human aldehyde dehydrogenase 2 promoter is antagonized by the chicken ovalbumin upstream promoter family of orphan receptors, ARCH BIOCH, 380(1), 2000, pp. 192-200
Authors:
Birkenkamp, KU
Esselink, MT
Kruijer, W
Vellenga, E
Citation: Ku. Birkenkamp et al., Differential effects of interleukin-3 and interleukin-1 on the proliferation and interleukin-6 protein secretion of acute myeloid leukemic cells; theinvolvement of ERK, p38 and STAT5, EUR CYTOKIN, 10(4), 1999, pp. 479-490
Authors:
Birkenkamp, KU
Dokter, WHA
Esselink, MT
Jonk, LJC
Kruijer, W
Vellenga, E
Citation: Ku. Birkenkamp et al., A dual function for p38 MAP kinase in hematopoietic cells: involvement in apoptosis and cell activation, LEUKEMIA, 13(7), 1999, pp. 1037-1045
Authors:
Tuyt, LML
Dokter, WHA
Birbenkamp, K
Koopmans, SB
Lummen, C
Kruijer, W
Vellenga, E
Citation: Lml. Tuyt et al., Extracellular-regulated kinase 1/2, Jun N-terminal kinase, and c-Jun are involved in NF-kappa B-dependent IL-6 expression in human monocytes, J IMMUNOL, 162(8), 1999, pp. 4893-4902
Authors:
Blanchard, JM
Bernableu, C
Eick, D
Hesketh, JE
Kruijer, W
Citation: Jm. Blanchard et al., Effect of transforming growth factor beta on proto-oncogenes, tumor suppressor genes and cell cycle regulators: Growth arrest versus apoptosis, BIOM HLTH R, 24, 1998, pp. 112-116